NASDAQ: RARE       Ultragenyx Pharmaceu
Last Price Today's Change   Day's Range   Trading Volume
56.26   -0.71 (1.25%)  55.129 - 56.825  81,639


Avg Volume (4 weeks):727,172
4 Weeks Range:41.43 - 63.92
4 Weeks Price Volatility (%):
52 Weeks Range:35.41 - 74.50
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Ultragenyx Pharmaceuticals is a biotechnology company, focused on the identification, development, and commercialization of products that treat genetic diseases. The business focuses on treating ultra-rare and debilitating diseases. The company develops biologic candidates. One example of Ultragenyx’s products currently in clinical trials is KRN23, a human-monoclonal antibody that binds and reduces the biological activity of fibroblast growth factor 23 to enhance low phosphate levels in patients with either X-linked hypophosphatemia or tumor-induced osteomalacia. Additionally, the company produces products for fatty acid oxidation disorders and treatments for GNE myopathy. The company generates the vast majority of its revenue in the United States.

  Be the first to like this.


2821  2492  418  3238 

Top 10 Active Counters
 CELG 108.24+0.11 
 AVP 5.60-0.05 
 NIO 4.13-0.53 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 ACHN 6.915+0.785 
 BBT 54.24+0.75 
 AMD 49.10-1.25 
 CHK 0.542-0.016 
Partners & Brokers